Control (n = 25) | RA (n = 38) | Significance (p) | |
---|---|---|---|
Age (years)a | 56 (42, 59.5) | 61 (50.50–70.25) | 0.027* |
Gender (female) | 21 (84.0 %) | 32 (84.2 %) | 0.982 |
Nicotine use (smokers) | 3 (12.0 %) | 13 (34.2 %) | 0.041* |
Arterial hypertension | 12 (48.0 %) | 18 (47.4 %) | 0.960 |
Obesity (BMI > 25 kg/m2) | 11 (44.0 %) | 19 (50 %) | 0.500 |
Hyperlipidemia | 5 (20.0 %) | 12 (31.6 %) | 0.250 |
Diabetes mellitus (type II) | 1 (4.0 %) | 5 (13.2 %) | 0.214 |
ANA positivity (>1:80) | – | 5 (13.9 %) | – |
BSG (mm/h)a | – | 25 (14.00–55.50) | – |
VAS (mm)a | – | 7 (5.75–8.00) | – |
CRP (mg/dL)a | – | 1.1 (0.36–2.62) | – |
DAS 28 (BSG)a | – | 5.10 (4.10–5.75) | – |
DAS 28 (CRP)a | – | 4.50 (3.45–4.92) | – |
Disease duration (years)a | – | 11 (4.00–17.00) | – |
RF (IU/ml)a | – | 103 (6.55–322.50) | – |
CCP (IU/ml)a | – | 117 (7.25–340.00) | – |
TJCa | – | 4.50 (1.00–7.75) | – |
SJCa | – | 2 (0.00–4.00) | – |